BMGL

Basel Medical Group Ltd Ordinary Shares
NASDAQHEALTHCAREMEDICAL CARE FACILITIES

Key Statistics

Market Cap
$9.74M
P/E Ratio
EPS
$-5.71
Beta
52W High
$54.60
52W Low
$4.60
50-Day MA
$7.36
200-Day MA
$10.45
Dividend Yield
Profit Margin
-68.20%
Forward P/E
PEG Ratio

About Basel Medical Group Ltd Ordinary Shares

Basel Medical Group Ltd provides healthcare services. The company is headquartered in Singapore.

Official WebsiteUSAFY End: June

Fundamentals

Revenue (TTM)$14.74M
Gross Profit (TTM)$2.06M
EBITDA$-4.06M
Operating Margin-32.80%
Return on Equity-147.40%
Return on Assets-15.50%
Revenue/Share (TTM)$8.82
Book Value$3.10
Price-to-Book2.69
Price-to-Sales (TTM)0.66
EV/Revenue1.688
EV/EBITDA11.86
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)67.10%
Shares Outstanding$1.57M
Float501,420
% Insiders54.32%
% Institutions0.32%

Historical Volatility

HV 10-Day
155.29%
HV 20-Day
121.06%
HV 30-Day
150.89%
HV 60-Day
120.07%
HV Rank

Volatility is currently expanding

Latest News

QingSong Health Corp (2661.HK) and Basel Medical Sign Strategic Cooperation Memorandum to Explore AI Healthcare Services in Southeast Asia

BEIJING, June 10, 2026 /PRNewswire/ -- Recently, QingSong Health Corp (2661.HK) and Basel Medical Group Ltd announced the signing of a Memorandum of Strategic Cooperation. The two parties intend to explore cooperation in AI-enabled healthcare services, insurance-related healthcare solutions, and cross-border medical services in Southeast Asia.

PRNewsWire6/10/2026Neutral
BMGL to Effect Reverse Share Split on June 22, 2026

SINGAPORE, June 10, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”), a medical clinic operator in Singapore, today announced that the Company's board of directors has approved the consolidation of the Company's issued and outstanding shares of the Company on a 1-for-12 ratio with the marketplace effective date of June 22, 2026.

GlobeNewsWire6/10/2026Neutral
BMGL Investors Have Opportunity to Join Basel Medical Group Ltd Fraud Investigation with the Schall Law Firm

LOS ANGELES, April 23, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Basel Medical Group Ltd (“Basel” or “the Company”) (NASDAQ: BMGL) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

GlobeNewsWire4/23/2026Neutral

More HEALTHCARE Stocks

Data last updated: 7/9/2026